Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Commonwealth Biotechnologies Acquires China Peptide Producer

publication date: Jun 10, 2009

Commonwealth Biotechnologies, Inc. has agreed to acquire privately owned GL Biochem (Shanghai) Ltd., a manufacturer of peptide products and reagents. In 2008, GL Biochem produced $13 million of revenue and $2 million of net income, representing a compound annual growth rate of 40%. In an all-stock transaction, CBI will issue 6.56 million shares to owners of GL Biochem, which will give them 51% ownership of CBI. More details...

Stock Symbol: (NSDQ: CBTE)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital